Evidence map›Paper›PMID 33233676›Full record

ArticleMolecules (Basel, Switzerland)2020

Activity of Pterostilbene Metabolites against Liver Steatosis in Cultured Hepatocytes.

Jenifer Trepiana, Stéphanie Krisa, María Puy Portillo

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Nutrients · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Jenifer TrepianaNutrition and Obesity Group, Department of Nutrition and Food Science, Faculty of Pharmacy, University of Basque Country (UPV/EHU) and Lucio Lascaray Research Center, 01006 Vitoria-Gasteiz, Spain.ORCID 0000-0003-1316-5923
Stéphanie KrisaUniversité de Bordeaux, UR Œnologie, MIB, EA 4577, USC 1366 INRA, 33882 Villenave d'Ornon, France.
María Puy PortilloNutrition and Obesity Group, Department of Nutrition and Food Science, Faculty of Pharmacy, University of Basque Country (UPV/EHU) and Lucio Lascaray Research Center, 01006 Vitoria-Gasteiz, Spain.ORCID 0000-0003-0210-6549
Instituto de Salud Carlos III · ESUniversité de Bordeaux · FR

Funding

Instituto de Salud Carlos III CIBERobn CB12/03/30007Ministerio de Economía y Competitividad-Fondo Europeo de Desarrollo Regional AGL-2015-65719-R MINECO/FEDERUniversity of the Basque Country GIU 18/173
6 · The paper itself

Abstract

Pterostilbene is a dimethyl ether derivative of resveratrol, less metabolized than its analogue, due to the substitution of two hydroxyl groups with methoxyl groups. Nevertheless, the amounts of pterostilbene phase II metabolites found in plasma and tissues are higher than those of the parent compound. The first aim of this study was to assess whether pterostilbene-4'-

Indexed as

AnimalsBiomarkersBiopsyCell LineCell SurvivalDisease Models, AnimalFatty AcidsFatty LiverHepatocytesImmunohistochemistryLipid MetabolismLipogenesisMiceStilbenesTriglyceridesBiomarkersFatty AcidspterostilbeneStilbenesTriglyceridesAML-12 hepatocytesliver steatosispterostilbene-4′-O-glucuronidepterostilbene-4′-O-sulfatepterostilbene metabolites

Identifiers

PMID33233676
PMCPMC7699812
OpenAlexW3101525852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.